newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Announces Passage of Reverse Stock Split Proposal at its Special Meeting of Stockholders

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company's stockholders approved the Reverse Stock Split proposal at its reconvened Special Meeting of Stockholders.